News
Darren Aftahi, who maintained his “Buy” rating and $6.00 target in a May 15 update, says the company’s Paraguay buildout puts ...
Paradigm Capital analyst Daniel Rosenberg lowered his target price on Sylogist to $12.75 from $13.00 in a May 15 research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback